Impact of genetic polymorphisms in CYP2C8 and rosiglitazone intake on the urinary excretion of dihydroxyeicosatrienoic acids.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Pharmacogenomics (London)

• Publication date

  2008-02-27

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2217/14622416.9.3.277PMID 18303964
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Characterization of novel CYP2C8 haplotypes and their contribution to paclitaxel and repaglinide metabolism

  2008cited by this paper
• DiscrEET regulators of homeostasis: epoxyeicosatrienoic acids, cytochrome P450 epoxygenases and vascular inflammation.

  2007cited by this paper
• CYP2C8 haplotype structures and their influence on pharmacokinetics of paclitaxel in a Japanese population

  2007cited by this paper
• CYP2J2 and CYP2C8 polymorphisms and coronary heart disease risk: the Atherosclerosis Risk in Communities (ARIC) study

  2007cited by this paper
• The risk of myocardial infarction in patients with reduced activity of cytochrome P450 2C9

  2007cited by this paper
• 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-alpha.

  2006cited by this paper
• Genetic variation in soluble epoxide hydrolase (EPHX2) and risk of coronary heart disease: The Atherosclerosis Risk in Communities (ARIC) study.

  2006cited by this paper
• Endothelium-derived epoxyeicosatrienoic acids and vascular function.

  2006cited by this paper
• Cytochrome P450 epoxygenase CYP2J2 and the risk of coronary artery disease.

  2006cited by this paper
• Pharmacokinetics and pharmacodynamics of rosiglitazone in relation to CYP2C8 genotype

  2006cited by this paper
• Tu-P7:67 The role of thrombomodulin in the neointima formation in mouse carotid ligation model

  2006cited by this paper
• Vascular protective effects of cytochrome p450 epoxygenase-derived eicosanoids.

  2005cited by this paper
• Polymorphic Organic Anion Transporting Polypeptide 1B1 is a Major Determinant of Repaglinide Pharmacokinetics

  2005cited by this paper
• Effect of CYP2C8 genotype on rosiglitazone pharmacokinetics

  2005cited by this paper
• Identification and quantification of metabolites of arachidonic acid from cultures of endothelial cells by HPLC-MS2

  2005cited by this paper
• Biosynthesis of epoxyeicosatrienoic acids varies between polymorphic CYP2C enzymes.

  2005cited by this paper
• Examination of 209 Drugs for Inhibition of Cytochrome P450 2C8

  2005cited by this paper
• Eicosapentaenoic acid metabolism by cytochrome P450 enzymes of the CYP2C subfamily.

  2005cited by this paper
• Risk of Coronary Artery Disease Associated With Polymorphism of the Cytochrome P450 Epoxygenase CYP2J2

  2004cited by this paper
• Enhancement of Cardiac L-Type Ca2+ Currents in Transgenic Mice with Cardiac-Specific Overexpression of CYP2J2

  2004cited by this paper
• Effects of CYP2C9 polymorphisms on the pharmacokinetics of R- and S-phenprocoumon in healthy volunteers.

  2004cited by this paper
• Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels.

  2004cited by this paper
• Soluble epoxide hydrolase inhibition protects the kidney from hypertension-induced damage.

  2004cited by this paper
• Fatty acid-binding proteins inhibit hydration of epoxyeicosatrienoic acids by soluble epoxide hydrolase.

  2003cited by this paper
• Polymorphisms in human soluble epoxide hydrolase.

  2003cited by this paper
• Polymorphism in CYP2C8 is associated with reduced plasma concentrations of repaglinide

  2003cited by this paper
• Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction.

  2003cited by this paper
• Comparative effects of thiazolidinediones on in vitro P450 enzyme induction and inhibition.

  2003cited by this paper
• Cloning of CYP2J2 gene and identification of functional polymorphisms.

  2002cited by this paper
• The simultaneous quantification of cytochrome P450 dependent linoleate and arachidonate metabolites in urine by HPLC-MS/MS DOI 10.1194/jlr.D200018-JLR200

  2002cited by this paper
• Epoxygenase Pathways of Arachidonic Acid Metabolism*

  2001cited by this paper
• Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid.

  2001cited by this paper
• Enhanced renal microvascular reactivity to angiotensin II in hypertension is ameliorated by the sulfonimide analog of 11,12-epoxyeicosatrienoic acid

  2001cited by this paper
• Increased CYP2J expression and epoxyeicosatrienoic acid formation in spontaneously hypertensive rat kidney.

  2000cited by this paper
• Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids

  2000cited by this paper
• In vitro inhibitory effects of troglitazone and its metabolites on drug oxidation activities of human cytochrome P450 enzymes: comparison with pioglitazone and rosiglitazone.

  2000cited by this paper
• Anti-inflammatory properties of cytochrome P450 epoxygenase-derived eicosanoids.

  1999cited by this paper
• P450 subfamily CYP2J and their role in the bioactivation of arachidonic acid in extrahepatic tissues.

  1999cited by this paper
• Cytochrome P450 2C is an EDHF synthase in coronary arteries

  1999cited by this paper
• Arachidonic acid metabolism by human cytochrome P450s 2C8, 2C9, 2E1, and 1A2: regioselective oxygenation and evidence for a role for CYP2C enzymes in arachidonic acid epoxygenation in human liver microsomes.

  1995cited by this paper
• Endogenous biosynthesis of arachidonic acid epoxides in humans: increased formation in pregnancy-induced hypertension.

  1990cited by this paper

• Exploratory focused pharmacogenetic testing reveals novel markers associated with risperidone pharmacokinetics in Saudi children with autism

  2024cites this paper
• Effects of genetic polymorphisms of CYP2J2, CYP2C9, CYP2C19, CYP4F2, CYP4F3 and CYP4A11 enzymes in preeclampsia and gestational hypertension

  2023cites this paper
• Role of cytochrome P450 2C8 genetic polymorphism and epoxygenase uncoupling in periodontal remodelling affecting orthodontic treatment

  2021cites this paper
• Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients

  2018cites this paper
• Pharmacogenetic Factors That Affect Drug Metabolism and Efficacy in Type 2 Diabetes Mellitus

  2017cites this paper
• The contribution of CYP2C gene subfamily involved in epoxygenase pathway of arachidonic acids metabolism to hypertension susceptibility in Russian population

  2017cites this paper
• Polymorphisms of CYP2C8, CYP2C9 and CYP2C19 and risk of coronary heart disease in Russian population.

  2017cites this paper
• Impact of CYP2C8*3 polymorphism on in vitro metabolism of imatinib to N-desmethyl imatinib

  2016cites this paper
• P450 Enzymes in Lipid Oxidation

  2015cites this paper
• Impact of CYP2C8 single nucleotide polymorphisms on in-vitro metabolism of imatinib to N-desmethyl imatinib

  2015cites this paper
• ROLE OF CYTOCHROME P450 FATTY ACID METABOLISM IN THE PATHOPHYSIOLOGY OF SUBARACHNOID HEMORRHAGE

  2014cites this paper
• SNPs and taxane toxicity in breast cancer patients.

  2014cites this paper
• Pharmacogenomics and pharmacogenetics of thiazolidinediones: role in diabetes and cardiovascular risk factors.

  2014cites this paper
• Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).

  2013cites this paper
• Pharmacogenetics in Drug Metabolism: Role of Phase I Enzymes

  2012cites this paper
• Polymorphisms in cytochromes P450 2C8 and 3A5 are associated with paclitaxel neurotoxicity

  2011cites this paper
• EETs and Oxo-ETE in Airway Diseases

  2011cites this paper
• Cerivastatin in vitro metabolism by CYP2C8 variants found in patients experiencing rhabdomyolysis

  2010cites this paper
• Human CYP2C8: structure, substrate specificity, inhibitor selectivity, inducers and polymorphisms.

  2009cites this paper
• Polymorphism of human cytochrome P450 enzymes and its clinical impact

  2009cites this paper
• Epoxyeicosatrienoic acids: formation, metabolism and potential role in tissue physiology and pathophysiology

  2009cites this paper
• Effects of SLCO1B1 polymorphism on the pharmacokinetics of the oral antidiabetic drugs repaglinide, nateglinide, rosiglitazone, and pioglitazone

  2008cites this paper
• Determination of epoxyeicosatrienoic acids in human red blood cells and plasma by GC/MS in the NICI mode.

  2008cites this paper
• Quantitation of oxylipins in biological samples, focusing on plasma and urine.

  year unknowncites this paper